Foundation for innovation
in Cardiometabolism and Nutrition

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

Nature Communications

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau